Webinar: Mesh Litigation Update

/Webinar: Mesh Litigation Update
Webinar: Mesh Litigation Update 2018-04-19T14:11:29+00:00

Webinar: Mesh Litigation Update

DATE: June 6, 2018 5pm-7pm

REGISTER NOW

Speakers & Topics

Organizer: Michael Monheit – Overview, Q&A, FDA reporting, Issues with Social Media

Michael Monheit, Esq.

Michael Monheit is the managing partner for Monheit Law. Michael has over 20 years of experience as an attorney. He has been involved in many mass tort pharmaceutical and medical device cases including Topamax, Vioxx, Prempro and many others. He was former chair of the Fosamax litigation group at the American Association of Justice and has been appointed lead counsel in several class actions in childhood lead poisoning paint litigation. Michael currently works on many mass torts involving women’s issues including Essure, Mirena, Taxotere, Talc, the Power Morcellator, and Mesh.

 

Moderator: Jane Akre – Introduction of speakers

Jane Akre, editor, Mesh News Desk

Jane Akre is the founder and editor of the Mesh Medical Device News Desk .  She has been a journalist for nearly 30 years working as a broadcaster, anchor and reporter at stations all around the country as well as CNN.  Ms. Akre has won numerous awards including the Society of Professional Journalists Award for Ethics as well as the Goldman Prize, North America 2001 for environmental reporting.  She and her husband successfully challenged News Corp after it tried to suppress a story about synthetic bovine growth hormone produced by Monsanto and used in much of the nation’s dairy supply. That whistleblowing lawsuit was featured in the documentary, “The Corporation.”

Speaker: Robert Bendavid, MD – Topic: issues/options related to revision surgery

Dr. Robert Bendavid

Dr. Robert Bendavid is a leading hernia surgeon and past president and a founding father of the American Hernia Society.  Dr. Bendavid has performed thousands of procedures and is presently associated with the Shouldice Hospital in Toronto.

He also believes in non-mesh repairs for hernia whenever possible and Shouldice does not use mesh in its hernia repairs.

Shouldice Clinic in Thornhill, Ontario, is the only licensed hospital in the world dedicated to tension-free and natural tissue technique for hernia repair.

Speaker: Joseph Saunders, Esq. – Topic: Vaginal Mesh settlement process, MDL remand process, & trial of individual cases, the difficult balance between justice and efficiency.

Joe Saunders, Esq.

Joseph H. Saunders is a Civil Trial Lawyer who is Board-Certified by the National Board of Trial Advocacy and by the Florida Bar. He was admitted to the California Bar in 1981 and to the Florida Bar in 1982.

He is AV Rated by Martindale-Hubbell Legal Directory. His most recent publication is a March 2012 peer- reviewed article in the American Association for Justice Trial Magazine on Daubert Qualification of Regulatory Expert Witnesses in Pharmaceutical and Medical Device cases.

Since becoming involved in the Fen-Phen Diet Drug litigation 19 years ago, he and the law firm have specialized in plaintiff pharmaceutical and medical device litigation. Most of the law practice practice has been in multidistrict litigation and class action litigation.

Mr. Saunders has been appointed to federal plaintiff steering committees in Pelvic Mesh (MDLs 2187, 2325, 2326, 2327, 2387, and 2440 -West Virginia), Biomet Hip Implant (MDL 2391-Indiana) Zicam Cold Medicine (MDL 2096-Arizona), and in the New York State Court’s Coordinated Bausch & Lomb Contact Lens Solution litigation (New York City).

He served as co-class counsel in the U.S. District Court for the Middle District of Florida in the ground water pollution litigation of Sher v. Raytheon. Case No. 8:08- CIV-889-T-33-AEP

Mr. Saunders has been involved in national multidistrict medical product liability litigation since 1999, including MDL 1203 (In re: Diet Drugs), MDL 1410 (Sulzer Hip Implant); MDL 1431 (Baycol); MDL 1438 (Rezulin); MDL 1596 (Zyprexa); MDL 1657 (Vioxx); MDL 1708 (Guidant Heart Device); MDL 1726 (Medtronic Implantable Defibrillator); MDL 1785 (Renu Contact Lens Solution); MDL 1905 (Medtronic Heart Device Leads); MDL 2047 (Chinese Drywall); and MDL 2158 (Zimmer Durom Cup Hip Implant).

He is a member of the AAJ PAC Task Force and AAJ PAC Board of Trustees. He is currently the Chairman of the Board of Directors for Operation PAR, Inc., a 501(c)(3) mental health and substance abuse treatment organization, and an advisory board member of Tampa Bay Watch, Inc., a non-profit environmental organization. He is also past President and member of the Executive Committee of Alpha House, Inc., a residential facility for pregnant homeless women.

Mr. Saunders graduated from the University of San Francisco Law School in 1981 where he served as a staff member for the Law Review. He founded the Saunders and Walker law firm in 1987.  Saunders & Walker P.A. is located in Pinellas Park, Florida.

Speaker: Joseph Fantini, Esq. – Topic: status of Hernia Mesh litigation, legal process, what to expect.

Joe Fantini, Esq.

Joseph Fantini is an attorney with The Rosen Law firm. His practice involves pharmaceutical and medical device mass tort litigation involving complex medical, scientific and legal issues.

Joe has been named a Rising Star in Pennsylvania Super Lawyers® since 2014.

Joe earned his law degree from Widener University School of Law in 2009. At Widener University School of Law, he was the recipient of the Certificate of Achievement in Food and Drug Law, which is awarded to the top student in each section. Joe also served as a law clerk in the Philadelphia County Court of Common Pleas for the Honorable Arnold L. New.

Before his work in the past 7 years for people harmed by medical device and pharmaceutical products, Joe worked at an international insurance defense firm where he represented companies in personal injury, product liability, and commercial disputes. This experience provides him with an advantage in negotiating on behalf of his clients by allowing him to anticipate defense strategies and tactics.

Joe is admitted to practice in Pennsylvania, New Jersey, as well as before the United States District Courts for the Eastern District of Pennsylvania and the District of New Jersey. He is an active member of the Philadelphia Bar Association, Philadelphia Bar Association Young Lawyers Division, and the Philadelphia Trial Lawyers Association. He presently serves as a member of the Executive Committee for the Philadelphia Bar Association-Young Lawyers Division.

Speaker: Bruce Rosenberg – Topic: patient’s perspective, support, advocacy

Bruce Rosenberg, patient advocate

Bruce Rosenberg is a mesh-injured patient advocate.  Trained as a social worker, 10 years ago he established the nonprofit National Meshoma Foundation to provide patient advocacy, education and referrals to men and women injured by mesh implants.

REGISTER NOW

** IF YOU ARE REPRESENTED BY COUNSEL, PLEASE CONTACT YOUR LAWYER BEFORE SIGNING UP TO ATTEND. **

I HEREBY AGREE TO THE BELOW BY SIGNING UP TO ATTEND.
1.   Each participant in the Webinar has a joint and common belief and interest in establishing the necessary proof to establish that the manufacturers of medical mesh are legally responsible for the adverse effects caused by these devices.

2.   Each participant in the Webinar represents that he/she is not presently representing any medical device manufacturer, their employees or members or affiliated entities or insurers, in connection with the hernia and/or vaginal mesh investigation, and is not an employee, agent, or representative of those companies.  Each further agrees not disclose any portion of, or any copies of, any information obtained from this webinar to any pharmaceutical company or affiliated entity, their agents, employees, independent contractors, or to any person, firm, or entity where the materials may be  seen, copied, accessed, or otherwise reached by any pharmaceutical company or affiliated entities.

3.   Each participant affirms that he/she has a community of interest in the coordinated investigation and prosecution of the liability and causation issues relating to these matters.​

4.  Each participant affirms there is ample evidence that these devices are unreasonably dangerous and cause severe harm that was not adequately warned for should not be marketed and sold. He/she further agree that these devices contain manufacturing defects that void any defense that protect manufacturers from claims and further agrees that these claims are not preempted by Federal Law.

BY SIGNING UP FOR THIS WEBINAR, I HEREBY SWEAR AND AFFIRM UNDER THE PENALTY OF PERJURY THAT THE FOREGOING IS TRUE AND CORRECT TO THE BEST OF MY KNOWLEDGE

REGISTER NOW